153 related articles for article (PubMed ID: 19597933)
1. Acute intrastriatal administration of quinolinic acid affects the expression of the coat protein AP-2 and its interaction with membranes.
Borgonovo J; Seltzer A; Sosa MA
J Neural Transm (Vienna); 2009 Oct; 116(10):1201-8. PubMed ID: 19597933
[TBL] [Abstract][Full Text] [Related]
2. Mutant huntingtin affects endocytosis in striatal cells by altering the binding of AP-2 to membranes.
Borgonovo JE; Troncoso M; Lucas JJ; Sosa MA
Exp Neurol; 2013 Mar; 241():75-83. PubMed ID: 23219902
[TBL] [Abstract][Full Text] [Related]
3. Modulation of quinolinic acid-induced depletion of striatal NADPH diaphorase and enkephalinergic neurons by inhibition of nitric oxide synthase.
Kalisch BE; Jhamandas K; Beninger RJ; Boegman RJ
Brain Res; 1999 Jan; 817(1-2):151-62. PubMed ID: 9889356
[TBL] [Abstract][Full Text] [Related]
4. Early effects of intrastriatal injections of quinolinic acid on microtubule-associated protein-2 and neuropeptides in rat basal ganglia.
Bordelon YM; Chesselet MF
Neuroscience; 1999; 93(3):843-53. PubMed ID: 10473250
[TBL] [Abstract][Full Text] [Related]
5. Quinolinic acid neurotoxicity: in vivo increased copper and manganese content in rat corpus striatum after quinolinate intrastriatal injection.
Santamaría A; Ríos C; Pérez P; Flores A; Galván-Arzate S; Osorio-Rico L; Solís F
Toxicol Lett; 1996 Oct; 87(2-3):113-9. PubMed ID: 8914619
[TBL] [Abstract][Full Text] [Related]
6. Serotonin depletion exacerbates changes in striatal gene expression following quinolinic acid injection.
Cummings TJ; Walker PD
Brain Res; 1996 Dec; 743(1-2):240-8. PubMed ID: 9017251
[TBL] [Abstract][Full Text] [Related]
7. MK-801, an N-methyl-D-aspartate receptor antagonist, blocks quinolinic acid-induced lipid peroxidation in rat corpus striatum.
Santamaría A; Ríos C
Neurosci Lett; 1993 Sep; 159(1-2):51-4. PubMed ID: 8264978
[TBL] [Abstract][Full Text] [Related]
8. Thalidomide inhibition of vascular remodeling and inflammatory reactivity in the quinolinic acid-injected rat striatum.
Ryu JK; Jantaratnotai N; McLarnon JG
Neuroscience; 2009 Oct; 163(2):601-8. PubMed ID: 19591904
[TBL] [Abstract][Full Text] [Related]
9. Developmental regulation of BDNF and NT-3 expression by quinolinic acid in the striatum and its main connections.
Checa N; Canals JM; Alberch J
Exp Neurol; 2000 Sep; 165(1):118-24. PubMed ID: 10964490
[TBL] [Abstract][Full Text] [Related]
10. Free radical scavenger OPC-14117 attenuates quinolinic acid-induced NF-kappaB activation and apoptosis in rat striatum.
Nakai M; Qin ZH; Wang Y; Chase TN
Brain Res Mol Brain Res; 1999 Jan; 64(1):59-68. PubMed ID: 9889320
[TBL] [Abstract][Full Text] [Related]
11. Characterization of striatal cultures with the effect of QUIN and NMDA.
Kumar U
Neurosci Res; 2004 May; 49(1):29-38. PubMed ID: 15099701
[TBL] [Abstract][Full Text] [Related]
12. Mice heterozygous for neurotrophin-3 display enhanced vulnerability to excitotoxicity in the striatum through increased expression of N-methyl-D-aspartate receptors.
Torres-Peraza J; Pezzi S; Canals JM; Gavaldà N; García-Martínez JM; Pérez-Navarro E; Alberch J
Neuroscience; 2007 Jan; 144(2):462-71. PubMed ID: 17081696
[TBL] [Abstract][Full Text] [Related]
13. Modulation of striatal quinolinate neurotoxicity by elevation of endogenous brain kynurenic acid.
Harris CA; Miranda AF; Tanguay JJ; Boegman RJ; Beninger RJ; Jhamandas K
Br J Pharmacol; 1998 May; 124(2):391-9. PubMed ID: 9641558
[TBL] [Abstract][Full Text] [Related]
14. Nuclear factor-kappa B contributes to excitotoxin-induced apoptosis in rat striatum.
Qin ZH; Wang Y; Nakai M; Chase TN
Mol Pharmacol; 1998 Jan; 53(1):33-42. PubMed ID: 9443930
[TBL] [Abstract][Full Text] [Related]
15. A comparative analysis of the neuroprotective properties of competitive and uncompetitive N-methyl-D-aspartate receptor antagonists in vivo: implications for the process of excitotoxic degeneration and its therapy.
Massieu L; Thedinga KH; McVey M; Fagg GE
Neuroscience; 1993 Aug; 55(4):883-92. PubMed ID: 7694181
[TBL] [Abstract][Full Text] [Related]
16. Quinolinic acid induces disrupts cytoskeletal homeostasis in striatal neurons. Protective role of astrocyte-neuron interaction.
Pierozan P; Ferreira F; de Lima BO; Pessoa-Pureur R
J Neurosci Res; 2015 Feb; 93(2):268-84. PubMed ID: 25306914
[TBL] [Abstract][Full Text] [Related]
17. Transgenic mice expressing a Huntington's disease mutation are resistant to quinolinic acid-induced striatal excitotoxicity.
Hansson O; Petersén A; Leist M; Nicotera P; Castilho RF; Brundin P
Proc Natl Acad Sci U S A; 1999 Jul; 96(15):8727-32. PubMed ID: 10411943
[TBL] [Abstract][Full Text] [Related]
18. VEGF receptor antagonist Cyclo-VEGI reduces inflammatory reactivity and vascular leakiness and is neuroprotective against acute excitotoxic striatal insult.
Ryu JK; McLarnon JG
J Neuroinflammation; 2008 May; 5():18. PubMed ID: 18492281
[TBL] [Abstract][Full Text] [Related]
19. 3-Hydroxykynurenine potentiates quinolinate but not NMDA toxicity in the rat striatum.
Guidetti P; Schwarcz R
Eur J Neurosci; 1999 Nov; 11(11):3857-63. PubMed ID: 10583474
[TBL] [Abstract][Full Text] [Related]
20. NMDA and non-NMDA receptor-mediated excitotoxicity are potentiated in cultured striatal neurons by prior chronic depolarization.
Chen Q; Surmeier DJ; Reiner A
Exp Neurol; 1999 Sep; 159(1):283-96. PubMed ID: 10486197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
